India's Bharat Biotech says vaccine 93.4% effective against severe COVID-19 - Reuters India

1. India's Bharat Biotech says vaccine 93.4% effective against severe COVID-19  Reuters India
2. Ocugen’s COVID-19 Vaccine Co-Development Partner, Bharat Biotech, Shares Phase 3 Results Demonstrating 77.8% Protection against Overall Disease  Yahoo Finance
3. India's homegrown Covid-19 vaccine has 78% efficacy against symptomatic infections, developer says  CNN
4. The Latest: Indian-made vaccine works against all variants  Associated Press
5. Covaxin Phase 3 trial data out; gives an efficacy of 77.8% against symptomatic Covid-19  TIMES NOW
6. View Full Coverage on Google News

from Top stories - Google News https://ift.tt/3yo9ZE1